UNICANCER
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.unicancer.fr
Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.
- Conditions
- Interventions
- First Posted Date
- 2024-06-10
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 170
- Registration Number
- NCT06450314
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 120
- Registration Number
- NCT06333314
- Locations
- 🇫🇷
Hôpital Saint-Antoine, Paris, Île-de-France, France
🇫🇷Institut de Cancérologie de l'Ouest, Saint-Herblain, France
🇫🇷Institut du Cancer Avignon-Provence, Avignon, France
Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
- Conditions
- Interventions
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 336
- Registration Number
- NCT06276465
- Locations
- 🇫🇷
Groupe Hospitalier Bretagne Sud, Lorient, France
🇫🇷Centre Azuréen de Cancérologie, Mougins, France
🇫🇷CHU de Saint-Etienne, Saint-Étienne, France
Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 73
- Registration Number
- NCT06245356
- Locations
- 🇫🇷
Institut du Cancer d'Avignon, Avignon, France
🇫🇷CHU Jean Minjoz, Besançon, France
🇫🇷Centre Hospitalier de Cholet, Cholet, France
Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC
- Conditions
- Interventions
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 354
- Registration Number
- NCT06078384
- Locations
- 🇫🇷
CHU Amiens Picardie_Site Sud, Amiens, France
🇫🇷Institut Sainte Catherine, Avignon, France
🇫🇷Centre Hospitalier de la Côte Basque, Bayonne, France
Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
- Conditions
- Interventions
- First Posted Date
- 2023-08-03
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 220
- Registration Number
- NCT05973864
Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
- Conditions
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 30
- Registration Number
- NCT05800275
A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 400
- Registration Number
- NCT05639413
- Locations
- 🇫🇷
CH Fleyriat, Bourg-en-Bresse, France
🇫🇷Centre d'Oncologie Saint Yves, Vannes, France
🇫🇷Centre Hospitalier D'Avignon, Avignon, France
Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib
- First Posted Date
- 2022-11-22
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 162
- Registration Number
- NCT05625087
- Locations
- 🇫🇷
Clinique de l'Europe Amiens - CTHE, Amiens, France
🇫🇷Institut Bergonié, Bordeaux, France
🇫🇷Centre Hospitalier de Boulogne-sur-Mer, Boulogne-sur-Mer, France
Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 50
- Registration Number
- NCT05622071
- Locations
- 🇫🇷
Hôpital Avicenne, Bobigny, France
🇫🇷Hôpital Michallon, Grenoble, France
🇫🇷Institut Paoli Calmette, Marseille, France